SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-23-053242
Filing Date
2023-11-14
Accepted
2023-11-14 16:06:46
Documents
57
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ef20012461_10q.htm   iXBRL 10-Q 1196876
2 EXHIBIT 31.1 ef20012461_ex31-1.htm EX-31.1 12462
3 EXHIBIT 31.2 ef20012461_ex31-2.htm EX-31.2 12360
4 EXHIBIT 32.1 ef20012461_ex32-1.htm EX-32.1 5031
5 EXHIBIT 32.2 ef20012461_ex32-2.htm EX-32.2 4890
11 image01.jpg GRAPHIC 106712
12 image02.jpg GRAPHIC 95638
  Complete submission text file 0001140361-23-053242.txt   5824691

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20230930.xsd EX-101.SCH 32441
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdsb-20230930_cal.xml EX-101.CAL 35717
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pdsb-20230930_def.xml EX-101.DEF 150718
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20230930_lab.xml EX-101.LAB 523612
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20230930_pre.xml EX-101.PRE 289604
51 EXTRACTED XBRL INSTANCE DOCUMENT ef20012461_10q_htm.xml XML 768347
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 231406028
SIC: 2834 Pharmaceutical Preparations